Heartflow, Inc. HTFL
We take great care to ensure that the data presented and summarized in this overview for Heartflow, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in HTFL
Top Purchases
Top Sells
About HTFL
Insider Transactions at HTFL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2025
|
Bain Capital Life Sciences Investors, LLC |
BUY
Conversion of derivative security
|
Indirect |
12,448,158
+26.68%
|
$186,722,370
$15.2 P/Share
|
|
Aug 11
2025
|
Jeffrey C Lightcap Director |
BUY
Conversion of derivative security
|
Indirect |
6,697,556
+50.0%
|
-
|
|
Aug 11
2025
|
Casey M Tansey Director |
BUY
Conversion of derivative security
|
Direct |
16,447
+50.0%
|
-
|
|
Aug 11
2025
|
Casey M Tansey Director |
BUY
Conversion of derivative security
|
Indirect |
3,171,062
+50.0%
|
-
|
|
Aug 11
2025
|
Timothy C Barabe Director |
BUY
Conversion of derivative security
|
Direct |
131,578
+43.87%
|
-
|
|
Aug 11
2025
|
Marie L. Jones Chief Accounting Officer, VP |
BUY
Conversion of derivative security
|
Direct |
6,578
+39.22%
|
-
|
|
Aug 11
2025
|
Vikram Verghese Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
9,516
+6.14%
|
-
|
|
Aug 11
2025
|
William C Weldon Director |
BUY
Conversion of derivative security
|
Direct |
136,286
+41.44%
|
-
|
|
Aug 07
2025
|
Marie L. Jones Chief Accounting Officer, VP |
BUY
Grant, award, or other acquisition
|
Direct |
3,618
+50.0%
|
-
|
|
Aug 07
2025
|
Campbell Rogers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,052
+50.0%
|
-
|
|
Aug 07
2025
|
Vikram Verghese Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,052
+13.42%
|
-
|
|
Aug 07
2025
|
John C.M. Farquhar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,868
+12.14%
|
-
|
Last 12 Months Summary
Buy / Acquisition
22.7M
Shares
From
11
Insiders
| Conversion of derivative security | 22.6M shares |
|---|---|
| Grant, award, or other acquisition | 106K shares |
Sell / Disposition
0
Shares
From
0
Insiders